8-76704280-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_024721.5(ZFHX4):c.192C>T(p.Phe64=) variant causes a synonymous change. The variant allele was found at a frequency of 0.00171 in 1,614,002 control chromosomes in the GnomAD database, including 55 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0017 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 50 hom. )
Consequence
ZFHX4
NM_024721.5 synonymous
NM_024721.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.32
Genes affected
ZFHX4 (HGNC:30939): (zinc finger homeobox 4) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be part of chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 8-76704280-C-T is Benign according to our data. Variant chr8-76704280-C-T is described in ClinVar as [Benign]. Clinvar id is 790841.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00173 (263/152294) while in subpopulation SAS AF= 0.0285 (137/4814). AF 95% confidence interval is 0.0246. There are 5 homozygotes in gnomad4. There are 170 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 263 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZFHX4 | NM_024721.5 | c.192C>T | p.Phe64= | synonymous_variant | 2/11 | ENST00000651372.2 | |
ZFHX4 | NM_001410934.1 | c.192C>T | p.Phe64= | synonymous_variant | 2/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZFHX4 | ENST00000651372.2 | c.192C>T | p.Phe64= | synonymous_variant | 2/11 | NM_024721.5 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00173 AC: 264AN: 152176Hom.: 5 Cov.: 32
GnomAD3 genomes
AF:
AC:
264
AN:
152176
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00347 AC: 865AN: 249132Hom.: 18 AF XY: 0.00433 AC XY: 585AN XY: 135146
GnomAD3 exomes
AF:
AC:
865
AN:
249132
Hom.:
AF XY:
AC XY:
585
AN XY:
135146
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00171 AC: 2505AN: 1461708Hom.: 50 Cov.: 31 AF XY: 0.00234 AC XY: 1700AN XY: 727138
GnomAD4 exome
AF:
AC:
2505
AN:
1461708
Hom.:
Cov.:
31
AF XY:
AC XY:
1700
AN XY:
727138
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00173 AC: 263AN: 152294Hom.: 5 Cov.: 32 AF XY: 0.00228 AC XY: 170AN XY: 74468
GnomAD4 genome
AF:
AC:
263
AN:
152294
Hom.:
Cov.:
32
AF XY:
AC XY:
170
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
47
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at